Treatment of type 2 diabetes by free fatty acid receptor agonists
Dietary free fatty acids (FFAs), such as ω-3 fatty acids, regulate metabolic and anti-inflammatory processes, with many of these effects attributed to FFAs interacting with a family of G protein-coupled receptors. Selective synthetic ligands for Free Fatty Acid receptors (FFA1-4) have consequently b...
Main Authors: | Kenneth R Watterson, Brian D Hudson, Trond eUlven, Graeme eMilligan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-08-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fendo.2014.00137/full |
Similar Items
-
Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets
by: Trond eUlven
Published: (2012-10-01) -
FFAR from the Gut Microbiome Crowd: SCFA Receptors in T1D Pathology
by: Medha Priyadarshini, et al.
Published: (2021-05-01) -
Insulin Action, Glucose Homeostasis and Free Fatty Acid Metabolism: Insights From a Novel Model
by: Darko Stefanovski, et al.
Published: (2021-03-01) -
Long-Chain Fatty Acid Receptors Mediate Relaxation of the Porcine Lower Esophageal Sphincter
by: Ching-Chung Tsai, et al.
Published: (2019-05-01) -
Elevated free fatty acid level is associated with insulin-resistant state in nondiabetic Chinese people
by: Xin YL, et al.
Published: (2019-01-01)